Published in:
01-10-2021 | Acute Respiratory Distress-Syndrome | Original Article
Anti-inflammatory Effects of Sweroside on LPS-Induced ALI in Mice Via Activating SIRT1
Authors:
Juan Wang, Xiaolan Cai, Rui Ma, Dapeng Lei, Xinliang Pan, Fengshan Wang
Published in:
Inflammation
|
Issue 5/2021
Login to get access
Abstract
Sweroside, as one of the main components of Swertia L. in Gentianaceae, has the effect of clearing heat and detoxifying. In previous studies, sweroside has been reported to have anti-inflammatory effect on LPS-induced inflammation by alleviating NF-κB signaling pathway. In this paper, we investigate the anti-inflammatory effects of sweroside by establishing LPS-induced acute lung injury (ALI) model in mice. Experimental results showed that sweroside could reduce the wet-to-dry ratio of the lung and inhibit MPO activity. In addition, it turned out that sweroside reduced pathological changes in lung tissue and the numbers of inflammatory cells. Moreover, sweroside significantly reduced the levels of inflammatory cytokines and down-regulated the NF-κB signaling pathway. And the results demonstrated that sweroside could increase the expression of SIRT1, and the protective effects of sweroside on LPS-induced ALI were reversed by SIRT1 inhibitor EX-527. In conclusion, sweroside can protect LPS-induced ALI mice through inhibiting inflammation.